DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2023 Conference Call.

Related Keywords

Canada ,Australia ,Boston ,Massachusetts ,United States ,Netherlands ,China ,Dan Hultberg ,David Wambeke ,Scott Kellen ,Richard Kuntz ,Rick Pauls ,Francois Brisebois ,Alex Nowak ,Thomas Flaten ,Professor Of Medicine At Harvard Medical School ,National Academy Of Medicine ,Diamedica Therapeutics Inc ,Craig Hallum Capital Group ,Nasdaq ,Harvard Clinical Research Institute ,Medtronic ,National Institutes Of Health ,Division Of Clinical Biometrics ,Diamedica Therapeutics ,Call Transcript August ,Diamedica Therapeutics Second Quarter ,Investor Relations ,Cautionary Statement Note ,Risk Factors ,Chief Executive ,Chief Financial ,Chief Medical Officer ,Chief Scientific Officer ,Senior Vice President ,Before Medtronic ,Associate Professor ,Harvard Medical School ,Clinical Biometrics ,Interventional Cardiologist ,National Academy ,National Institutes ,Advancing Patient Care ,Chief Business Officer ,Lake Street ,Craig Hallum Capital ,